Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Multifunctional Wound Dressing with Stimuli-Responsive Drug Release and Antibacterial Action

Objective

Chronic wounds, including pressure ulcers and burns, pose a persistent global healthcare challenge, particularly among ageing and immobilised patients. Chronic wounds frequently exhibit impaired healing, a phenomenon attributable to a complex microenvironment characterised by chronic inflammation, persistent infection, poor vascularisation, and impaired tissue regeneration. Despite the considerable advances made in the field of medicine, current wound dressings are passive and largely ineffective in responding to these multifactorial conditions. There is an absence of the capacity to dynamically adapt, monitor local changes, or deliver therapeutic agents in a controlled manner. This results in delayed healing, recurrent infections, and significant healthcare costs. WOUND-ACT proposes a novel strategy to address these limitations through the design of a smart, multi-layered and multifunctional wound dressing capable of real-time wound monitoring and stimuli-responsive therapeutic drug release. The system is composed of three distinct layers, each with a specific function: (i) an inner antibacterial GeIMA-based hydrogel with ZnO particles doped with Ag or Mg, designed to suppress microbial colonization and biofilm formation; (ii) a central electroresponsive GeIMA-based hydrogel reinforced with carbon nanotubes and therapeutic nanocapsules, enabling on-demand drug delivery triggered by wound conditions; and (iii) an outer sensing layer that uses colorimetric indicators to detect pH and temperature changes associated with infection or inflammation. This integrated platform combines diagnostics and therapy in a single modular system that is adaptable to diverse wound types, healing stages, and patient profiles. The clinical scalability of the design is of significant potential, with the capacity to reduce healing times, minimise antibiotic use, reduce readmissions and substantially reduce healthcare costs. This marks a disruptive advance in personalised wound care.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2025-PF

See all projects funded under this call

Coordinator

FUNDACION IMDEA MATERIALES
Net EU contribution
€ 194 074,56
Address
CALLE ERIC KANDEL 2 PARQUE CIENTIFICO Y TECNOLOGICO TECNOGETAFE
28906 Getafe
Spain
Region
Comunidad de Madrid Comunidad de Madrid Madrid
Activity type
Research Organisations
Links
Total cost
No data